Successful Free Tissue Transfer in the Profoundly Hypercoagulable Glioblastoma Multiforme Patient: Surgical Experience and Anticoagulation Protocol

Abstract

Background Glioblastoma multiforme (GBM) produces a hypercoagulable environment and is associated the highest rates of deep venous thrombosis (DVT) and pulmonary emboli (PE) of any malignancy. The use of postoperative radiation in this generally compromised patient group is associated with the development of complex scalp wounds. Free tissue transfer reconstruction will be essential in selected cases despite the presence of an underlying hypercoagulable state.

Methods A 67-year-old female with a history of previous DVT presented with osteoradionecrosis and infected scalp wound following GBM treatment. She underwent reconstruction with a free vastus lateralis flap and skin graft. Initial anticoagulation was provided with intravenous heparin and transitioned to oral apixaban. Wound cultures demonstrated coagulase-negative Staphylococcus, Actinomyces neuii, and Peptoniphilus harei and were treated with a 6-week course of intravenous cefepime and vancomycin.

Results Despite the initial failure of a local scalp rotation flap, successful wound healing was achieved with a free muscle flap and a course of culture specific antibiotics. The patient succumbed to recurrent disease 22 months after surgery, underscoring the importance of limiting hospitalization and maximizing quality of life in this group of patients.

Conclusion Free tissue transfer can be successfully achieved in the hypercoagulable GBM patient. Heparin and apixaban were employed successfully in the prevention of thrombotic events. Antiplatelet therapy should also be considered to counteract platelet aggregation induced by the transmembrane glycoprotein (podoplanin) that is expressed on GBM tumor cells. Enzyme-linked immunosorbent assay testing (ELISA) of blood soluble podoplanin may help determine the degree of hypercoagulability and guide therapy.

Keywords

glioblastoma - free tissue flaps - thrombophilia

Publication History

Received: 20 May 2020

Accepted: 14 July 2020

Article published online:
13 September 2020

• References

• 1 Louis DN, Perry A, Reifenberger G. , et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016; 131 (06) 803-820
• 2 Knovich MA, Lesser GJ. The management of thromboembolic disease in patients with central nervous system malignancies. Curr Treat Options Oncol 2004; 5 (06) 511-517
• 3 Simanek R, Vormittag R, Hassler M. , et al. Venous thromboembolism and survival in patients with high-grade glioma. Neuro-oncol 2007; 9 (02) 89-95
• 4 Ladha H, Pawar T, Gilbert MR. , et al. Wound healing complications in brain tumor patients on Bevacizumab. J Neurooncol 2015; 124 (03) 501-506
• 5 Haubner F, Ohmann E, Pohl F, Strutz J, Gassner HG. Wound healing after radiation therapy: review of the literature. Radiat Oncol 2012; 7: 162
• 6 Edwin NC, Khoury MN, Sohal D, McCrae KR, Ahluwalia MS, Khorana AA. Recurrent venous thromboembolism in glioblastoma. Thromb Res 2016; 137: 184-188
• 7 Wirsching HG, Galanis E, Weller M. Glioblastoma. Handb Clin Neurol 2016; 134: 381-397
• 8 Reiss S, Zemmoura I, Joly A, Kün-Darbois JD, Laure B, Paré A. Muscle forehead flap: salvage surgery for closure of cutaneous fistula after cranioplasty exposure. World Neurosurg 2019; 122: 210-214
• 9 Levitt MR, Benedict WJ, Barton K. , et al. Management of scalp toxic epidermal necrolysis and cranial osteomyelitis with serratus anterior myocutaneous pedicle flap: a case report. J Burn Care Res 2007; 28 (03) 524-529
• 10 Karsy M, Yoon N, Boettcher L. , et al. Surgical treatment of glioblastoma in the elderly: the impact of complications. J Neurooncol 2018; 138 (01) 123-132
• 11 Riedl J, Ay C. Venous thromboembolism in brain tumors: Risk factors, molecular mechanisms, and clinical challenges. Semin Thromb Hemost 2019; 45 (04) 334-341
• 12 Farge D, Debourdeau P, Beckers M. , et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost 2013; 11 (01) 56-70
• 13 Shukla G, Alexander GS, Bakas S. , et al. Advanced magnetic resonance imaging in glioblastoma: a review. Linchuang Zhongliuxue Zazhi 2017; 6 (04) 40
• 14 Pope WB, Young JR, Ellingson BM. Advances in MRI assessment of gliomas and response to anti-VEGF therapy. Curr Neurol Neurosci Rep 2011; 11 (03) 336-344
• 15 Rong Y, Durden DL, Van Meir EG, Brat DJ. ‘Pseudopalisading’ necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 2006; 65 (06) 529-539
• 16 Hahn A, Bode J, Krüwel T. , et al. Glioblastoma multiforme restructures the topological connectivity of cerebrovascular networks. Sci Rep 2019; 9 (01) 11757
• 17 Martínez-González A, Calvo GF, Pérez Romasanta LA, Pérez-García VM. Hypoxic cell waves around necrotic cores in glioblastoma: a biomathematical model and its therapeutic implications. Bull Math Biol 2012; 74 (12) 2875-2896